At least half a dozen big banks are working with potential bidders for Kmart Corp.'s Pay Less drugstore chain, said to be worth as much as $1 billion.

The banks appear to be looking to finance mainly leveraged buyout firms, as opposed to strategic buyers in the retail industry.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.